An Economic Design of Rectifying Double Acceptance Sampling Plans via Maxima Nomination Sampling
Stochastics and Quality Control · 2017
DOI: 10.1515/eqc-2017-0018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stochastics and Quality Control, 2017. Verfasst von Mansooreh Razmkhah und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
In industry when a lot of items is sent for inspection, double acceptance sampling plans (DASP) are considered as a way to decide on acceptance or rejection of the lot. If the lot contains items with high sensitivity, then the measuring of quality characteristics is destructive or costly. So we are looking for a method to decide that it has high performance. Using the ranked set sampling (RSS) method will make it stricter and more accurate whether or not to accept a lot. Moreover, it is affordable and will not burden extra costs on the buyer or the producer. In this paper, by using a special type of RSS, with the name of maxima nomination sampling (MNS), we design a DASP with regards to the total loss function. The results indicate that the total loss function, which is acquired by the MNS method, has lower values than the one using the simple random sampling (SRS) method.
Zitieren
APA
Razmkhah, M., Gildeh, B. S., & Ahmadi, J. (2017). An Economic Design of Rectifying Double Acceptance Sampling Plans via Maxima Nomination Sampling. Stochastics and Quality Control. https://doi.org/10.1515/eqc-2017-0018
Vancouver
Razmkhah M, Gildeh BS, Ahmadi J. An Economic Design of Rectifying Double Acceptance Sampling Plans via Maxima Nomination Sampling. Stochastics and Quality Control. 2017. doi:10.1515/eqc-2017-0018
BibTeX
@article{Razmkhah2017,
author = {Razmkhah, Mansooreh and Gildeh, Bahram Sadeghpour and Ahmadi, Jafar},
title = {An Economic Design of Rectifying Double Acceptance Sampling Plans via Maxima Nomination Sampling},
journal = {Stochastics and Quality Control},
year = {2017},
doi = {10.1515/eqc-2017-0018}
}
EUVIMED